{"pmid":32240537,"title":"Post-donation COVID-19 identification in blood donors.","text":["Post-donation COVID-19 identification in blood donors.","The coronavirus disease 19 (COVID-19) outbreak, which was characterized as a pandemic on 11 March 2020 by the WHO, started in December 2019 with the emergence of pneumonia cases of unknown cause in Wuhan, Hubei, China [1]. SARS-CoV-2, the causative agent of COVID-19, are enveloped, non-segmented, single stranded positive sense RNA viruses and are classified as a sister clade to the prototype human and bat severe acute respiratory syndrome coronaviruses (SARS-CoVs) of the species Severe acute respiratory syndrome-related coronavirus [2]. So far, no respiratory virus, including SARS-CoV and the Middle East Respiratory Syndrome (MERS)-CoV, has been confirmed as transfusion-transmissible [3,4].","Vox Sang","Kwon, So-Yong","Kim, Eun-Jin","Jung, Yu Soek","Jang, Jin Sung","Cho, Nam-Sun","32240537"],"abstract":["The coronavirus disease 19 (COVID-19) outbreak, which was characterized as a pandemic on 11 March 2020 by the WHO, started in December 2019 with the emergence of pneumonia cases of unknown cause in Wuhan, Hubei, China [1]. SARS-CoV-2, the causative agent of COVID-19, are enveloped, non-segmented, single stranded positive sense RNA viruses and are classified as a sister clade to the prototype human and bat severe acute respiratory syndrome coronaviruses (SARS-CoVs) of the species Severe acute respiratory syndrome-related coronavirus [2]. So far, no respiratory virus, including SARS-CoV and the Middle East Respiratory Syndrome (MERS)-CoV, has been confirmed as transfusion-transmissible [3,4]."],"journal":"Vox Sang","authors":["Kwon, So-Yong","Kim, Eun-Jin","Jung, Yu Soek","Jang, Jin Sung","Cho, Nam-Sun"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240537","week":"202014|Mar 30 - Apr 05","doi":"10.1111/vox.12925","source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1662996001619705857,"score":7.6048946,"similar":[{"pmid":32004165,"title":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.","text":["Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.","BACKGROUND: Human infections with zoonotic coronaviruses (CoVs), including severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV, have raised great public health concern globally. Here, we report a novel bat-origin CoV causing severe and fatal pneumonia in humans. METHODS: We collected clinical data and bronchoalveolar lavage (BAL) specimens from five patients with severe pneumonia from Jin Yin-tan Hospital of Wuhan, Hubei province, China. Nucleic acids of the BAL were extracted and subjected to next-generation sequencing. Virus isolation was carried out, and maximum-likelihood phylogenetic trees were constructed. RESULTS: Five patients hospitalized from December 18 to December 29, 2019 presented with fever, cough, and dyspnea accompanied by complications of acute respiratory distress syndrome. Chest radiography revealed diffuse opacities and consolidation. One of these patients died. Sequence results revealed the presence of a previously unknown beta-CoV strain in all five patients, with 99.8% to 99.9% nucleotide identities among the isolates. These isolates showed 79.0% nucleotide identity with the sequence of SARS-CoV (GenBank NC_004718) and 51.8% identity with the sequence of MERS-CoV (GenBank NC_019843). The virus is phylogenetically closest to a bat SARS-like CoV (SL-ZC45, GenBank MG772933) with 87.6% to 87.7% nucleotide identity, but is in a separate clade. Moreover, these viruses have a single intact open reading frame gene 8, as a further indicator of bat-origin CoVs. However, the amino acid sequence of the tentative receptor-binding domain resembles that of SARS-CoV, indicating that these viruses might use the same receptor. CONCLUSION: A novel bat-borne CoV was identified that is associated with severe and fatal respiratory disease in humans.","Chin Med J (Engl)","Ren, Li-Li","Wang, Ye-Ming","Wu, Zhi-Qiang","Xiang, Zi-Chun","Guo, Li","Xu, Teng","Jiang, Yong-Zhong","Xiong, Yan","Li, Yong-Jun","Li, Xing-Wang","Li, Hui","Fan, Guo-Hui","Gu, Xiao-Ying","Xiao, Yan","Gao, Hong","Xu, Jiu-Yang","Yang, Fan","Wang, Xin-Ming","Wu, Chao","Chen, Lan","Liu, Yi-Wei","Liu, Bo","Yang, Jian","Wang, Xiao-Rui","Dong, Jie","Li, Li","Huang, Chao-Lin","Zhao, Jian-Ping","Hu, Yi","Cheng, Zhen-Shun","Liu, Lin-Lin","Qian, Zhao-Hui","Qin, Chuan","Jin, Qi","Cao, Bin","Wang, Jian-Wei","32004165"],"abstract":["BACKGROUND: Human infections with zoonotic coronaviruses (CoVs), including severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV, have raised great public health concern globally. Here, we report a novel bat-origin CoV causing severe and fatal pneumonia in humans. METHODS: We collected clinical data and bronchoalveolar lavage (BAL) specimens from five patients with severe pneumonia from Jin Yin-tan Hospital of Wuhan, Hubei province, China. Nucleic acids of the BAL were extracted and subjected to next-generation sequencing. Virus isolation was carried out, and maximum-likelihood phylogenetic trees were constructed. RESULTS: Five patients hospitalized from December 18 to December 29, 2019 presented with fever, cough, and dyspnea accompanied by complications of acute respiratory distress syndrome. Chest radiography revealed diffuse opacities and consolidation. One of these patients died. Sequence results revealed the presence of a previously unknown beta-CoV strain in all five patients, with 99.8% to 99.9% nucleotide identities among the isolates. These isolates showed 79.0% nucleotide identity with the sequence of SARS-CoV (GenBank NC_004718) and 51.8% identity with the sequence of MERS-CoV (GenBank NC_019843). The virus is phylogenetically closest to a bat SARS-like CoV (SL-ZC45, GenBank MG772933) with 87.6% to 87.7% nucleotide identity, but is in a separate clade. Moreover, these viruses have a single intact open reading frame gene 8, as a further indicator of bat-origin CoVs. However, the amino acid sequence of the tentative receptor-binding domain resembles that of SARS-CoV, indicating that these viruses might use the same receptor. CONCLUSION: A novel bat-borne CoV was identified that is associated with severe and fatal respiratory disease in humans."],"journal":"Chin Med J (Engl)","authors":["Ren, Li-Li","Wang, Ye-Ming","Wu, Zhi-Qiang","Xiang, Zi-Chun","Guo, Li","Xu, Teng","Jiang, Yong-Zhong","Xiong, Yan","Li, Yong-Jun","Li, Xing-Wang","Li, Hui","Fan, Guo-Hui","Gu, Xiao-Ying","Xiao, Yan","Gao, Hong","Xu, Jiu-Yang","Yang, Fan","Wang, Xin-Ming","Wu, Chao","Chen, Lan","Liu, Yi-Wei","Liu, Bo","Yang, Jian","Wang, Xiao-Rui","Dong, Jie","Li, Li","Huang, Chao-Lin","Zhao, Jian-Ping","Hu, Yi","Cheng, Zhen-Shun","Liu, Lin-Lin","Qian, Zhao-Hui","Qin, Chuan","Jin, Qi","Cao, Bin","Wang, Jian-Wei"],"date":"2020-02-01T11:00:00Z","year":2020,"_id":"32004165","week":"20205|Jan 27 - Feb 02","doi":"10.1097/CM9.0000000000000722","source":"PubMed","locations":["China","Hubei","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1663095626270769152,"score":236.89264},{"pmid":32226290,"pmcid":"PMC7098027","title":"Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.","text":["Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.","Coronaviruses (CoVs) are a group of enveloped, single-stranded positive genomic RNA viruses and some of them are known to cause severe respiratory diseases in human, including Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and the ongoing coronavirus disease-19 (COVID-19). One key element in viral infection is the process of viral entry into the host cells. In the last two decades, there is increasing understanding on the importance of the endocytic pathway and the autophagy process in viral entry and replication. As a result, the endocytic pathway including endosome and lysosome has become important targets for development of therapeutic strategies in combating diseases caused by CoVs. In this mini-review, we will focus on the importance of the endocytic pathway as well as the autophagy process in viral infection of several pathogenic CoVs inclusive of SARS-CoV, MERS-CoV and the new CoV named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and discuss the development of therapeutic agents by targeting these processes. Such knowledge will provide important clues for control of the ongoing epidemic of SARS-CoV-2 infection and treatment of COVID-19.","Int J Biol Sci","Yang, Naidi","Shen, Han-Ming","32226290"],"abstract":["Coronaviruses (CoVs) are a group of enveloped, single-stranded positive genomic RNA viruses and some of them are known to cause severe respiratory diseases in human, including Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and the ongoing coronavirus disease-19 (COVID-19). One key element in viral infection is the process of viral entry into the host cells. In the last two decades, there is increasing understanding on the importance of the endocytic pathway and the autophagy process in viral entry and replication. As a result, the endocytic pathway including endosome and lysosome has become important targets for development of therapeutic strategies in combating diseases caused by CoVs. In this mini-review, we will focus on the importance of the endocytic pathway as well as the autophagy process in viral infection of several pathogenic CoVs inclusive of SARS-CoV, MERS-CoV and the new CoV named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and discuss the development of therapeutic agents by targeting these processes. Such knowledge will provide important clues for control of the ongoing epidemic of SARS-CoV-2 infection and treatment of COVID-19."],"journal":"Int J Biol Sci","authors":["Yang, Naidi","Shen, Han-Ming"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32226290","week":"202014|Mar 30 - Apr 05","doi":"10.7150/ijbs.45498","keywords":["COVID-19","Coronaviruses","SARS-CoV-2","autophagy","endocytic pathway"],"source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1662819280256761856,"score":233.19142},{"pmid":32240543,"title":"The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy.","text":["The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy.","Coronaviruses are enveloped single-stranded RNA viruses belonging to the family of Coronaviridae. While initial research focused on their ability to cause enzootic infections, infections which have emerged in the past two decades demonstrate their ability to cross the species barrier and infect humans [1,2]. The ensuing epidemics have included Severe Acute Respiratory Syndrome (SARS) in 2002 and the more recent Middle East Respiratory Syndrome (MERS) in 2012, and have resulted in severe disease burden, mortality and economic disruption [3]. A novel flu-like coronavirus, emerging towards the end of 2019 and subsequently named SARS-CoV-2, has been associated with an epidemic initially focused in Wuhan, China.","Vox Sang","Franchini, Massimo","Farrugia, Albert","Velati, Claudio","Zanetti, Alessandro","Romano, Luisa","Grazzini, Giuliano","Lopez, Nadia","Pati, Ilaria","Marano, Giuseppe","Pupella, Simonetta","Maria Liumbruno, Giancarlo","32240543"],"abstract":["Coronaviruses are enveloped single-stranded RNA viruses belonging to the family of Coronaviridae. While initial research focused on their ability to cause enzootic infections, infections which have emerged in the past two decades demonstrate their ability to cross the species barrier and infect humans [1,2]. The ensuing epidemics have included Severe Acute Respiratory Syndrome (SARS) in 2002 and the more recent Middle East Respiratory Syndrome (MERS) in 2012, and have resulted in severe disease burden, mortality and economic disruption [3]. A novel flu-like coronavirus, emerging towards the end of 2019 and subsequently named SARS-CoV-2, has been associated with an epidemic initially focused in Wuhan, China."],"journal":"Vox Sang","authors":["Franchini, Massimo","Farrugia, Albert","Velati, Claudio","Zanetti, Alessandro","Romano, Luisa","Grazzini, Giuliano","Lopez, Nadia","Pati, Ilaria","Marano, Giuseppe","Pupella, Simonetta","Maria Liumbruno, Giancarlo"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240543","week":"202014|Mar 30 - Apr 05","doi":"10.1111/vox.12928","source":"PubMed","locations":["China","Wuhan","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1662996001799012352,"score":223.57336},{"pmid":32107119,"title":"Coronavirus Disease 2019: Coronaviruses and Blood Safety.","text":["Coronavirus Disease 2019: Coronaviruses and Blood Safety.","With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19). The World Health Organization declared COVID-19 in China as a Public Health Emergency of International Concern. Two other coronavirus infections-SARS in 2002-2003 and Middle East Respiratory Syndrome (MERS) in 2012-both caused severe respiratory syndrome in humans. All 3 of these emerging infectious diseases leading to a global spread are caused by beta-coronaviruses. Although coronaviruses usually infect the upper or lower respiratory tract, viral shedding in plasma or serum is common. Therefore, there is still a theoretical risk of transmission of coronaviruses through the transfusion of labile blood products. Because more and more asymptomatic infections are being found among COVID-19 cases, considerations of blood safety and coronaviruses have arisen especially in endemic areas. In this review, we detail current evidence and understanding of the transmission of SARS-CoV, MERS-CoV, and SARS-CoV-2 through blood products as of February 10, 2020, and also discuss pathogen inactivation methods on coronaviruses.","Transfus Med Rev","Chang, Le","Yan, Ying","Wang, Lunan","32107119"],"abstract":["With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19). The World Health Organization declared COVID-19 in China as a Public Health Emergency of International Concern. Two other coronavirus infections-SARS in 2002-2003 and Middle East Respiratory Syndrome (MERS) in 2012-both caused severe respiratory syndrome in humans. All 3 of these emerging infectious diseases leading to a global spread are caused by beta-coronaviruses. Although coronaviruses usually infect the upper or lower respiratory tract, viral shedding in plasma or serum is common. Therefore, there is still a theoretical risk of transmission of coronaviruses through the transfusion of labile blood products. Because more and more asymptomatic infections are being found among COVID-19 cases, considerations of blood safety and coronaviruses have arisen especially in endemic areas. In this review, we detail current evidence and understanding of the transmission of SARS-CoV, MERS-CoV, and SARS-CoV-2 through blood products as of February 10, 2020, and also discuss pathogen inactivation methods on coronaviruses."],"journal":"Transfus Med Rev","authors":["Chang, Le","Yan, Ying","Wang, Lunan"],"date":"2020-02-29T11:00:00Z","year":2020,"_id":"32107119","week":"20209|Feb 24 - Mar 01","doi":"10.1016/j.tmrv.2020.02.003","keywords":["2019-nCoV","Blood safety","COVID-19","Coronavirus","MERS","Pathogen inactivation technology","SARS","SARS-CoV-2"],"source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission"],"weight":1,"_version_":1662334544221569025,"score":216.10703},{"pmid":32226286,"pmcid":"PMC7098031","title":"Zoonotic origins of human coronaviruses.","text":["Zoonotic origins of human coronaviruses.","Mutation and adaptation have driven the co-evolution of coronaviruses (CoVs) and their hosts, including human beings, for thousands of years. Before 2003, two human CoVs (HCoVs) were known to cause mild illness, such as common cold. The outbreaks of severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) have flipped the coin to reveal how devastating and life-threatening an HCoV infection could be. The emergence of SARS-CoV-2 in central China at the end of 2019 has thrusted CoVs into the spotlight again and surprised us with its high transmissibility but reduced pathogenicity compared to its sister SARS-CoV. HCoV infection is a zoonosis and understanding the zoonotic origins of HCoVs would serve us well. Most HCoVs originated from bats where they are non-pathogenic. The intermediate reservoir hosts of some HCoVs are also known. Identifying the animal hosts has direct implications in the prevention of human diseases. Investigating CoV-host interactions in animals might also derive important insight on CoV pathogenesis in humans. In this review, we present an overview of the existing knowledge about the seven HCoVs, with a focus on the history of their discovery as well as their zoonotic origins and interspecies transmission. Importantly, we compare and contrast the different HCoVs from a perspective of virus evolution and genome recombination. The current CoV disease 2019 (COVID-19) epidemic is discussed in this context. In addition, the requirements for successful host switches and the implications of virus evolution on disease severity are also highlighted.","Int J Biol Sci","Ye, Zi-Wei","Yuan, Shuofeng","Yuen, Kit-San","Fung, Sin-Yee","Chan, Chi-Ping","Jin, Dong-Yan","32226286"],"abstract":["Mutation and adaptation have driven the co-evolution of coronaviruses (CoVs) and their hosts, including human beings, for thousands of years. Before 2003, two human CoVs (HCoVs) were known to cause mild illness, such as common cold. The outbreaks of severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) have flipped the coin to reveal how devastating and life-threatening an HCoV infection could be. The emergence of SARS-CoV-2 in central China at the end of 2019 has thrusted CoVs into the spotlight again and surprised us with its high transmissibility but reduced pathogenicity compared to its sister SARS-CoV. HCoV infection is a zoonosis and understanding the zoonotic origins of HCoVs would serve us well. Most HCoVs originated from bats where they are non-pathogenic. The intermediate reservoir hosts of some HCoVs are also known. Identifying the animal hosts has direct implications in the prevention of human diseases. Investigating CoV-host interactions in animals might also derive important insight on CoV pathogenesis in humans. In this review, we present an overview of the existing knowledge about the seven HCoVs, with a focus on the history of their discovery as well as their zoonotic origins and interspecies transmission. Importantly, we compare and contrast the different HCoVs from a perspective of virus evolution and genome recombination. The current CoV disease 2019 (COVID-19) epidemic is discussed in this context. In addition, the requirements for successful host switches and the implications of virus evolution on disease severity are also highlighted."],"journal":"Int J Biol Sci","authors":["Ye, Zi-Wei","Yuan, Shuofeng","Yuen, Kit-San","Fung, Sin-Yee","Chan, Chi-Ping","Jin, Dong-Yan"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32226286","week":"202014|Mar 30 - Apr 05","doi":"10.7150/ijbs.45472","keywords":["COVID-19","MERS-CoV","SARS-CoV","SARS-CoV-2","animal reservoir","bats","coronavirus"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1662819280313384960,"score":206.75026}]}